Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI®(encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation
2024-08-30 20:44
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
2024-08-30 19:34
Fosun's Management: Globalization + Innovation + Asset-light Operations for Sustained and Stable Profits
2024-08-30 18:41
Breaking News | Sanyou Bio Launches Comprehensive Monkeypox Product Line
2024-08-30 18:00
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations
2024-08-30 11:01
/DISREGARD RELEASE: Celltrion USA/
2024-08-30 08:35
Remarkable Announcement on Significant Fluctuation of the UTime's Share Price
2024-08-30 00:33
Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London
2024-08-29 21:51
CARsgen® Announces 2024 Interim Results
2024-08-29 20:50
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms
2024-08-29 20:42
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics
2024-08-29 20:30
Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts
2024-08-29 20:30
ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions
2024-08-29 20:00
So-Young Announces Receipt of Minimum Bid Price Notice from Nasdaq
2024-08-29 17:30
Discover the Top 6 Highlights of Medtec 2024 and Explore the Latest Industry Trends
2024-08-29 17:00
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results
2024-08-29 14:31
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results
2024-08-29 14:00
Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan
2024-08-29 13:38
Smartee Hosts Breakthrough GS Mandibular Repositioning Therapy Conference in Singapore
2024-08-29 12:47
Smartee Showcases Iconic Orthodontic Solutions in Hong Kong, Expands Global Reach
2024-08-29 12:46
1
42
43
44
45
46
1596